Search Results for Kadcyla

Showing 1 – 2

NICE, Roche Reach Deal on Breast Cancer Drug By Michael Mezher - Published 15 June 2017

Patients in the UK could soon get access to Roche's targeted breast cancer drug Kadcyla (trastuzumab emtansine) through the National Health Service (NHS) as early as next month, the National Institute for Health and Care Excellence (NICE) said on Thursday.

Categories: News, Europe, NICE, Biologics and biotechnology, Reimbursement

Tags: NICE, Roche, Kadcyla, Herceptin, Trastuzumab

UK's NICE Rejects Roche's Breast Cancer Drug Kadcyla, Citing Major Cost Concerns By Louise Zornoza, RegLink News - Published 08 August 2014

The UK’s National Institute for Health and Care Excellence (NICE) has issued final draft guidance confirming its earlier rejection of Roche’s breast cancer drug treatment Kadcyla for National Health Service (NHS) coverage.

Categories: News, Europe, NICE, Reimbursement

Tags: NICE, Final Draft Guidance, Roche, Kadcyla, Breast Cancer, Cost